Semaglutide

Use semaglutide as a GLP-1 agonist for obesity and metabolic treatment, often finding meaningful benefit at about 1 to 2 mg weekly rather than pushing all the way to 2.4 mg. The practical advantage is that many people get strong appetite and weight-control effects at these lower doses while potentially limiting nausea and other dose-related side effects.